HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Busiku Hamainza Selected Research

artemisinin (artemisinine)

7/2021Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
12/2014Comparison of a mobile phone-based malaria reporting system with source participant register data for capturing spatial and temporal trends in epidemiological indicators of malaria transmission collected by community health workers in rural Zambia.
1/2013Measuring coverage in MNCH: accuracy of measuring diagnosis and treatment of childhood malaria from household surveys in Zambia.
9/2012Reductions in artemisinin-based combination therapy consumption after the nationwide scale up of routine malaria rapid diagnostic testing in Zambia.
10/2011Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries.
10/2011Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
3/2009Early results of integrated malaria control and implications for the management of fever in under-five children at a peripheral health facility: a case study of Chongwe rural health centre in Zambia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Busiku Hamainza Research Topics

Disease

49Malaria
01/2022 - 03/2009
15Infections
09/2021 - 03/2009
5Fever (Fevers)
10/2013 - 03/2009
4Falciparum Malaria (Plasmodium falciparum Malaria)
09/2021 - 11/2014
2Parasitic Diseases (Parasitic Disease)
08/2015 - 01/2011
2Pneumonia (Pneumonitis)
11/2012 - 09/2010
1Reinfection
11/2014
1Anemia
01/2011

Drug/Important Bio-Agent (IBA)

13Antimalarials (Antimalarial Agents)IBA
02/2021 - 03/2009
9InsecticidesIBA
12/2021 - 03/2009
9Pharmaceutical PreparationsIBA
01/2020 - 10/2011
7artenimol (dihydroartemisinin)IBA
01/2022 - 08/2015
7piperaquineIBA
01/2022 - 08/2015
7artemisinin (artemisinine)IBA
07/2021 - 03/2009
6Indicators and Reagents (Reagents)IBA
09/2021 - 09/2012
6Lumefantrine Drug Combination Artemether (Coartem)FDA Link
07/2021 - 09/2010
4Pyrethrins (Pyrethroids)FDA Link
08/2020 - 12/2012
3pirimiphos methyl (Aktel)IBA
04/2021 - 02/2016
33-O-(methylthiomethyl)apiitol tetraacetateIBA
05/2015 - 04/2015
2insulin receptor-related receptor (IRR)IBA
04/2021 - 01/2014
2Complement System Proteins (Complement)IBA
01/2020 - 08/2015
2Amoxicillin (Wymox)FDA LinkGeneric
11/2012 - 09/2010
1Chloroquine (Aralen)FDA LinkGeneric
07/2021
1AntigensIBA
04/2019
1Azure Stains (Giemsa Stain)IBA
04/2019
1PolyestersIBA
04/2018
1decamethrin (deltamethrin)IBA
02/2016
1OrganophosphatesIBA
02/2016
1cyhalothrinIBA
02/2016
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
11/2014
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
01/2014
1DDTIBA
12/2012
1Anti-Bacterial Agents (Antibiotics)IBA
09/2010

Therapy/Procedure

12Mass Drug Administration
01/2022 - 05/2015
7Therapeutics
12/2014 - 03/2009
3Insecticide-Treated Bednets
03/2016 - 01/2011
1Chemoprevention
12/2021
1Mosquito Nets
01/2021